Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer

Photodynamic therapy (PDT) is a valuable treatment method for vulvar intraepithelial neoplasia (VIN). It allows for the treatment of a multifocal disease with minimal tissue destruction. 5-Aminolevulinic acid (5-ALA) is the most commonly used prodrug, which is converted in the heme pathway to protop...

Full description

Bibliographic Details
Main Authors: Beata Joanna Mossakowska, Somayeh Shahmoradi Ghahe, Dominik Cysewski, Anna Fabisiewicz, Barbara Tudek, Janusz Aleksander Siedlecki
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/8/4117
_version_ 1797445987719970816
author Beata Joanna Mossakowska
Somayeh Shahmoradi Ghahe
Dominik Cysewski
Anna Fabisiewicz
Barbara Tudek
Janusz Aleksander Siedlecki
author_facet Beata Joanna Mossakowska
Somayeh Shahmoradi Ghahe
Dominik Cysewski
Anna Fabisiewicz
Barbara Tudek
Janusz Aleksander Siedlecki
author_sort Beata Joanna Mossakowska
collection DOAJ
description Photodynamic therapy (PDT) is a valuable treatment method for vulvar intraepithelial neoplasia (VIN). It allows for the treatment of a multifocal disease with minimal tissue destruction. 5-Aminolevulinic acid (5-ALA) is the most commonly used prodrug, which is converted in the heme pathway to protoporphyrin IX (PpIX), an actual photosensitizer (PS). Unfortunately, not all patients treated with PDT undergo complete remission. The main cause of their failure is resistance to anticancer therapy. In many cancers, resistance to various anticancer treatments is correlated with increased activity of the DNA repair protein apurinic/apyrimidinic endonuclease 1 (APE1). Enhanced activity of drug pumps may also affect the effectiveness of therapy. To investigate whether multidrug resistance mechanisms underlie PDT resistance in VIN, porphyrins were isolated from sensitive and resistant vulvar cancer cells and their culture media. APE1 activity was measured, and survival assay after PDT combined with APE1 inhibitor was performed. Our results revealed that resistant cells accumulated and effluxed less porphyrins than sensitive cells, and in response to PDT, resistant cells increased APE1 activity. Moreover, PDT combined with inhibition of APE1 significantly decreased the survival of PDT-resistant cells. This means that resistance to PDT in vulvar cancer may be the result of alterations in the heme synthesis pathway. Moreover, increased APE1 activity may be essential for the repair of PDT-mediated DNA damage, and inhibition of APE1 activity may increase the efficacy of PDT.
first_indexed 2024-03-09T13:33:58Z
format Article
id doaj.art-092b855c87444b6daeb9b06c979dffef
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T13:33:58Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-092b855c87444b6daeb9b06c979dffef2023-11-30T21:14:12ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-04-01238411710.3390/ijms23084117Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar CancerBeata Joanna Mossakowska0Somayeh Shahmoradi Ghahe1Dominik Cysewski2Anna Fabisiewicz3Barbara Tudek4Janusz Aleksander Siedlecki5Department of Molecular and Translational Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Roentgena 5, 02-781 Warsaw, PolandInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5a, 02-106 Warsaw, PolandInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5a, 02-106 Warsaw, PolandDepartment of Molecular and Translational Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Roentgena 5, 02-781 Warsaw, PolandInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5a, 02-106 Warsaw, PolandDepartment of Molecular and Translational Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Roentgena 5, 02-781 Warsaw, PolandPhotodynamic therapy (PDT) is a valuable treatment method for vulvar intraepithelial neoplasia (VIN). It allows for the treatment of a multifocal disease with minimal tissue destruction. 5-Aminolevulinic acid (5-ALA) is the most commonly used prodrug, which is converted in the heme pathway to protoporphyrin IX (PpIX), an actual photosensitizer (PS). Unfortunately, not all patients treated with PDT undergo complete remission. The main cause of their failure is resistance to anticancer therapy. In many cancers, resistance to various anticancer treatments is correlated with increased activity of the DNA repair protein apurinic/apyrimidinic endonuclease 1 (APE1). Enhanced activity of drug pumps may also affect the effectiveness of therapy. To investigate whether multidrug resistance mechanisms underlie PDT resistance in VIN, porphyrins were isolated from sensitive and resistant vulvar cancer cells and their culture media. APE1 activity was measured, and survival assay after PDT combined with APE1 inhibitor was performed. Our results revealed that resistant cells accumulated and effluxed less porphyrins than sensitive cells, and in response to PDT, resistant cells increased APE1 activity. Moreover, PDT combined with inhibition of APE1 significantly decreased the survival of PDT-resistant cells. This means that resistance to PDT in vulvar cancer may be the result of alterations in the heme synthesis pathway. Moreover, increased APE1 activity may be essential for the repair of PDT-mediated DNA damage, and inhibition of APE1 activity may increase the efficacy of PDT.https://www.mdpi.com/1422-0067/23/8/4117photodynamic therapyphotosensitizerprotoporphyrin IXheme metabolismmultidrug resistanceDNA repair
spellingShingle Beata Joanna Mossakowska
Somayeh Shahmoradi Ghahe
Dominik Cysewski
Anna Fabisiewicz
Barbara Tudek
Janusz Aleksander Siedlecki
Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer
International Journal of Molecular Sciences
photodynamic therapy
photosensitizer
protoporphyrin IX
heme metabolism
multidrug resistance
DNA repair
title Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer
title_full Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer
title_fullStr Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer
title_full_unstemmed Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer
title_short Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer
title_sort mechanisms of resistance to photodynamic therapy pdt in vulvar cancer
topic photodynamic therapy
photosensitizer
protoporphyrin IX
heme metabolism
multidrug resistance
DNA repair
url https://www.mdpi.com/1422-0067/23/8/4117
work_keys_str_mv AT beatajoannamossakowska mechanismsofresistancetophotodynamictherapypdtinvulvarcancer
AT somayehshahmoradighahe mechanismsofresistancetophotodynamictherapypdtinvulvarcancer
AT dominikcysewski mechanismsofresistancetophotodynamictherapypdtinvulvarcancer
AT annafabisiewicz mechanismsofresistancetophotodynamictherapypdtinvulvarcancer
AT barbaratudek mechanismsofresistancetophotodynamictherapypdtinvulvarcancer
AT januszaleksandersiedlecki mechanismsofresistancetophotodynamictherapypdtinvulvarcancer